Minimizing progestin associated breakthrough bleeding
US5622943A · kind A · utility
7Cited by
0References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 6, 1994 |
| Grant date | Apr 22, 1997 |
| Priority date | — |
| Expiry date | Dec 6, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for minimizing menstrual bleeding irregularities in individuals using progestin-only pharmaceutical preparations, such as contraceptives, is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.